IBDEI1KX ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28032,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,28033,0)
 ;;=V10.12^^162^1791^59
 ;;^UTILITY(U,$J,358.3,28033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28033,1,4,0)
 ;;=4^V10.12
 ;;^UTILITY(U,$J,358.3,28033,1,5,0)
 ;;=5^H/O Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,28033,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,28034,0)
 ;;=V10.60^^162^1791^60
 ;;^UTILITY(U,$J,358.3,28034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28034,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,28034,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,28034,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,28035,0)
 ;;=V10.11^^162^1791^61
 ;;^UTILITY(U,$J,358.3,28035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28035,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,28035,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,28035,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,28036,0)
 ;;=V10.79^^162^1791^62
 ;;^UTILITY(U,$J,358.3,28036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28036,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,28036,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,28036,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,28037,0)
 ;;=V10.82^^162^1791^69
 ;;^UTILITY(U,$J,358.3,28037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28037,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,28037,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,28037,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,28038,0)
 ;;=V10.02^^162^1791^64
 ;;^UTILITY(U,$J,358.3,28038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28038,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,28038,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,28038,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,28039,0)
 ;;=V10.43^^162^1791^65
 ;;^UTILITY(U,$J,358.3,28039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28039,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,28039,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,28039,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,28040,0)
 ;;=V10.46^^162^1791^66
 ;;^UTILITY(U,$J,358.3,28040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28040,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,28040,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,28040,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,28041,0)
 ;;=V10.06^^162^1791^67
 ;;^UTILITY(U,$J,358.3,28041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28041,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,28041,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,28041,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,28042,0)
 ;;=V10.52^^162^1791^68
 ;;^UTILITY(U,$J,358.3,28042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28042,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,28042,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,28042,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,28043,0)
 ;;=V10.04^^162^1791^71
 ;;^UTILITY(U,$J,358.3,28043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28043,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,28043,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,28043,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,28044,0)
 ;;=V10.47^^162^1791^72
 ;;^UTILITY(U,$J,358.3,28044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28044,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,28044,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,28044,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,28045,0)
 ;;=V10.83^^162^1791^70
 ;;^UTILITY(U,$J,358.3,28045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28045,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,28045,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,28045,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,28046,0)
 ;;=285.22^^162^1791^8
 ;;
 ;;$END ROU IBDEI1KX
